MindWalk Holdings Corp. (HYFT)
NASDAQ: HYFT · Real-Time Price · USD
1.070
-0.090 (-7.76%)
At close: Mar 27, 2026, 4:00 PM EDT
1.050
-0.020 (-1.87%)
Pre-market: Mar 30, 2026, 8:02 AM EDT
MindWalk Holdings Revenue
MindWalk Holdings had revenue of 4.16M CAD in the quarter ending January 31, 2026, with 52.42% growth. This brings the company's revenue in the last twelve months to 28.08M, up 95.87% year-over-year. In the fiscal year ending April 30, 2025, MindWalk Holdings had annual revenue of 24.52M with 0.01% growth.
Revenue (ttm)
28.08M CAD
Revenue Growth
+95.87%
P/S Ratio
2.57
Revenue / Employee
275,333 CAD
Employees
102
Market Cap
53.14M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Apr 30, 2025 | 24.52M | 2.00K | 0.01% |
| Apr 30, 2024 | 24.52M | 3.85M | 18.65% |
| Apr 30, 2023 | 20.67M | 1.30M | 6.72% |
| Apr 30, 2022 | 19.36M | 1.45M | 8.11% |
| Apr 30, 2021 | 17.91M | 3.85M | 27.41% |
| Apr 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Apr 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| TScan Therapeutics | 10.33M |
| Immutep | 5.28M |
| Lipocine | 1.98M |
| ImageneBio | 800.00K |
| Mereo BioPharma Group | 500.00K |
| Entera Bio | 124.00K |
HYFT News
- 17 days ago - MindWalk Holdings Corp. (HYFT) Q3 2026 Earnings Call Transcript - Seeking Alpha
- 18 days ago - MindWalk Holdings Corp. Reports Q3 Fiscal 2026 Financial Results - Business Wire
- 23 days ago - MindWalk Announces B Cell Llama™, a Nanobody Discovery Platform Designed for the Bispecific and Cell Therapy Era - Business Wire
- 27 days ago - MindWalk Holdings Corp. to Report Third Quarter Fiscal Year 2026 Financial Results on March 12, 2026 - Business Wire
- 2 months ago - MindWalk Applies HYFT® Technology to Detect Functional Adjacency Linked to Portfolio Risk in AI-Designed Therapeutics - Business Wire
- 2 months ago - MindWalk Validates Platform Precision with Breakthrough Discovery Targeting Pathogenic TDP-43 in Neurodegenerative Disease - Business Wire
- 2 months ago - REPEAT/MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Business Wire
- 2 months ago - MindWalk Advances Universal Influenza Program with a Breakthrough Functional Insight - Business Wire